Complete lymph node dissection or observation in treating patients with localized melanoma and sentinel node metastasis who have undergone sentinel lymphadenectomy

Journal of Drugs in Dermatology, August, 2007

Sponsors and Collaborators: John Wayne Cancer Institute at Saint John's Health Center and National Cancer Institute (NCI). This randomized phase III trial is studying complete lymph node dissection to see how well it works compared to observation in treating patients with localized melanoma and sentinel node metastasis who have undergone sentinel lymphadenectomy.

Condition        Intervention                Phase

Melanoma (Skin)  Procedure: diagnostic test  Phase III
                 Procedure: lymphadenectomy
                 Procedure: observation
                 Procedure: quality-of-life
                   assessment
                 Procedure: supportive
                   care/therapy
                 Procedure: surgery
                 Procedure: ultrasonography

Study ID Numbers: CDR0000513043; JWCI-MORD-LM/SL-CLND-1102

ClinicalTrials.gov Identifier: NCT00389571

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2007 Gale Group
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale